Skip to content

Evaluation of ALLERgen Specific Vaccination of DOG Allergic Patients in Swedish Practice - ALLERDOG SWEDEN

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-517649-15-00
Acronym
ALLERDOG
Enrollment
40
Registered
2025-01-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis due to dog allergy

Brief summary

Improvement in Rhinoconjunctivitis Total Symptom Score (RTSS) and visual analogue scale (VAS) registered 30 min after provocation with dog dander before and after one year treatment with Alutard SQ Dog.

Detailed description

Occurrence of AEs and SAEs., Conjunctions between levels of total IgE and specific IgE (Can f 1, Can f 2, Can f 4, Can f 5, Can f 6) and the treatment effect of Alutard SQ dog., Improvement of PNIF and PEF after contact with dogs before and after treatment with Alutard SQ Ddog.

Interventions

DRUGALUTARD SQ epitel
DRUGsuspension - 553 Hund
DRUGLivostin 0
DRUG5 mg/ml ögondroppar
DRUGsuspension
DRUGDesloratadine Sandoz 5 mg filmdragerade tabletter
DRUGNasonex 50 mikrogram/dos nässpray

Sponsors

Karolinska Institutet
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Design outcomes

Primary

MeasureTime frame
Improvement in Rhinoconjunctivitis Total Symptom Score (RTSS) and visual analogue scale (VAS) registered 30 min after provocation with dog dander before and after one year treatment with Alutard SQ Dog.

Secondary

MeasureTime frame
Occurrence of AEs and SAEs., Conjunctions between levels of total IgE and specific IgE (Can f 1, Can f 2, Can f 4, Can f 5, Can f 6) and the treatment effect of Alutard SQ dog., Improvement of PNIF and PEF after contact with dogs before and after treatment with Alutard SQ Ddog.

Countries

Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026